© J. Poirier 2022

Dr. Youla Tsantrizos, Ph.D., McGill University, Canada Dr. Tsantrizos is a well recognized medicinal chemist who has worked for more than 10 years as Group Leader for the Canadian medicinal chemistry program of Boehringer Ingelheim. She is now an assistant professor of Chemistry at McGill university where she has elaborated an Alzheimer therapeutic program in partnership with Dr. Judes Poirier. Dr. Joseph Rochford, Ph.D., McGill University, Canada Dr. Rocheford has developed a solid expertise in animal models of memory loss and all the relevant behavioral tests normally used to characterize cognitive deficits. He also has extensive expertise in biostatistics. Dr. Serge Gauthier, McGill University, Canada Physician, Alzheimer’s Disease Clinic, Centre for Studies in Aging Area of expertise: Experimental treatments of Alzheimer’s and Parkinson’s diseases Dr. John Breitner, McGill University, Canada Founding Director of the PREVENT-AD Centre, Douglas Institute Montreal, Canada Areas of Expertise: Clinical drug trials and cognition  Dr. Sylvia Villeneuve, McGill University, Canada, Associate Director of the PREVENT-AD Research Centre, Douglas Institute Montreal, Canada Areas of Expertise: MRI and PET imaging, neuropsycholotyLipid physiology and Cardiovascular Clinical Trials Name Title Experience Anne Labonté  Reseach Assistant Laboratory Manager   Gabriel Aumont  B.Sc.  Ph.D. Student Isabel Sierra Flores M.Sc.  Ph.D. Student Marina Tedeshi Dauar  MD, M.Sc. Ph.D. Student   Judes Poirier, Ph.D,C.Q    Director Co-Founder     Cynthia Picard  Associate Director Senior Scientist Andrée-Ann Baril  Ph.D. Post-Doctoral Fellow   Marianne Chapleau  Ph.D. Post-Doctoral Fellow   Marc Quesnel  B.Sc. M.Sc. Student  

Our Team Consultants and Advisors